Why is it not reasonable to compare stocks in the same sector, even if they have a different product and cost structure ?
Because 'sector' is totally meaningless. An orphan drug has nothing in common with practice management software or ultrasound cleaning equipment. So it impossible to make any useful comparison.
Your NAB, QAN comments are febal…and the funny thing is we may soon have better PE ratios then they do!!
If the CUV P/E ratio is falling it is because the market thinks the growth prospects are very limited.
Why is it not reasonable to compare stocks in the same sector,...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.44 |
Change
-0.180(1.15%) |
Mkt cap ! $773.2M | |||
| Open | High | Low | Value | Volume |
| $15.60 | $15.75 | $15.39 | $751.4K | 48.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 173 | $15.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.54 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |